---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-390535"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2026-09-14T20:04:29+00:00"
generated_at: "2026-09-14T20:05:06.395974+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Kestra Medical raises FY27 revenue guidance to $141M after Q1 revenue up 60% to $31.0M

## Summary
- F1Q27 revenue of $31.0M, up 60% YoY; gross margin expanded to 56.5% from 45.7%.
- GAAP net loss widened to $44.1M from $25.8M; adjusted EBITDA loss was $24.0M vs $19.4M.
- FY27 revenue guidance raised to $141M, representing 48% growth compared to FY26.
- Cash and investments totaled $244.7M; total liquidity ~$320M including term-loan availability.
- Growth driven by WCD market expansion, competitive share gains, new sales territories, and higher in-network mix.

## SEC filing metadata
- accession: 0001193125-26-390535
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2026-09-14T20:04:29+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390535/0001193125-26-390535-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390535/ck0001877184-20260914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-390535
- JSON: https://secwatch.observer/filing/0001193125-26-390535.json
- Plain text: https://secwatch.observer/filing/0001193125-26-390535.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.